These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 32366491)

  • 1. Risk stratification in pulmonary arterial hypertension using Bayesian analysis.
    Kanwar MK; Gomberg-Maitland M; Hoeper M; Pausch C; Pittrow D; Strange G; Anderson JJ; Zhao C; Scott JV; Druzdzel MJ; Kraisangka J; Lohmueller L; Antaki J; Benza RL
    Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32366491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Do Patients With Low-Risk Pulmonary Arterial Hypertension Really Benefit From Upfront Combination Therapy?: Insight From the AMBITION Trial.
    Fauvel C; Liu Y; Correa-Jaque P; Kanwar MK; Vizza CD; Lin S; Benza RL
    Chest; 2023 Dec; 164(6):1518-1530. PubMed ID: 37356711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison Between REVEAL Lite 2 and COMPERA 2.0 for Risk Stratification in Pulmonary Arterial Hypertension.
    Sahay S; Villasmil Hernandez N; Wang F; Wooten M; Nguyen DT; Fauvel C; Benza R; Graviss EA
    Chest; 2024 Aug; 166(2):373-387. PubMed ID: 38447640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting Survival in Patients With Pulmonary Arterial Hypertension: The REVEAL Risk Score Calculator 2.0 and Comparison With ESC/ERS-Based Risk Assessment Strategies.
    Benza RL; Gomberg-Maitland M; Elliott CG; Farber HW; Foreman AJ; Frost AE; McGoon MD; Pasta DJ; Selej M; Burger CD; Frantz RP
    Chest; 2019 Aug; 156(2):323-337. PubMed ID: 30772387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the European Society of Cardiology/European Respiratory Society derived three- and four-strata risk stratification models in pulmonary arterial hypertension: introducing an internet-based risk stratification calculator.
    Ahmed A; Ahmed S; Kempe D; Rådegran G
    Eur Heart J Open; 2023 Mar; 3(2):oead012. PubMed ID: 36959867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Risk Stratification Scores in Pulmonary Arterial Hypertension: A Monocentric Retrospective Study at Lausanne University Hospital.
    Vraka A; Yerly P; Aubert JD
    Respiration; 2022; 101(6):565-576. PubMed ID: 35045412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of risk stratification scores and role of comorbidities in older vs younger patients with pulmonary arterial hypertension.
    Stolfo D; Barbisan D; Ameri P; Lombardi CM; Monti S; Driussi M; Zovatto IC; Gentile P; Howard L; Toma M; Pagnesi M; Collini V; Bauleo C; Guglielmi G; Adamo M; D'Angelo L; Nalli C; Sciarrone P; Moschella M; Zorzi B; Vecchiato V; Milani M; Di Poi E; Airò E; Metra M; Garascia A; Sinagra G; Lo Giudice F
    J Heart Lung Transplant; 2023 Aug; 42(8):1082-1092. PubMed ID: 37005100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of renal function in mortality risk assessment for pulmonary arterial hypertension.
    Zelt JGE; Hossain A; Sun LY; Mehta S; Chandy G; Davies RA; Contreras-Dominguez V; Dunne R; Doyle-Cox C; Wells G; Stewart DJ; Mielniczuk LM
    J Heart Lung Transplant; 2020 Jul; 39(7):675-685. PubMed ID: 32336606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension.
    Hoeper MM; Pausch C; Olsson KM; Huscher D; Pittrow D; Grünig E; Staehler G; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Park DH; Ewert R; Kaemmerer H; Kabitz HJ; Skowasch D; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H; Claussen M; Lange TJ; Rosenkranz S
    Eur Respir J; 2022 Jul; 60(1):. PubMed ID: 34737226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective Validation of the REVEAL 2.0 Risk Score With the Australian and New Zealand Pulmonary Hypertension Registry Cohort.
    Anderson JJ; Lau EM; Lavender M; Benza R; Celermajer DS; Collins N; Corrigan C; Dwyer N; Feenstra J; Horrigan M; Keating D; Kermeen F; Kotlyar E; McWilliams T; Rhodes B; Steele P; Thakkar V; Williams T; Whitford H; Whyte K; Weintraub R; Wrobel JP; Keogh A; Strange G
    Chest; 2020 Jan; 157(1):162-172. PubMed ID: 31563497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of the REVEAL Prognostic Equation and Risk Score Calculator in Incident Systemic Sclerosis-Associated Pulmonary Arterial Hypertension.
    Mullin CJ; Khair RM; Damico RL; Kolb TM; Hummers LK; Hassoun PM; Steen VD; Mathai SC;
    Arthritis Rheumatol; 2019 Oct; 71(10):1691-1700. PubMed ID: 31066998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Contemporary Risk Scores in All Groups of Pulmonary Hypertension: A Pulmonary Vascular Research Institute GoDeep Meta-Registry Analysis.
    Yogeswaran A; Gall H; Fünderich M; Wilkins MR; Howard L; Kiely DG; Lawrie A; Hassoun PM; Sirenklo Y; Torbas O; Sweatt AJ; Zamanian RT; Williams PG; Frauendorf M; Arvanitaki A; Giannakoulas G; Saleh K; Sabbour H; Cajigas HR; Frantz R; Al Ghouleh I; Chan SY; Brittain E; Annis JS; Pepe A; Ghio S; Orfanos S; Anthi A; Majeed RW; Wilhelm J; Ghofrani HA; Richter MJ; Grimminger F; Sahay S; Tello K; Seeger W;
    Chest; 2024 Sep; 166(3):585-603. PubMed ID: 38508334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. External validation of a refined four-stratum risk assessment score from the French pulmonary hypertension registry.
    Boucly A; Weatherald J; Savale L; de Groote P; Cottin V; Prévot G; Chaouat A; Picard F; Horeau-Langlard D; Bourdin A; Jutant EM; Beurnier A; Jevnikar M; Jaïs X; Simonneau G; Montani D; Sitbon O; Humbert M
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34737227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction Models and Scores in Pulmonary Hypertension: A Review.
    Mouratoglou SA; Bayoumy AA; Noordegraaf AV
    Curr Pharm Des; 2021; 27(10):1266-1276. PubMed ID: 33155897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry.
    Zelniker TA; Huscher D; Vonk-Noordegraaf A; Ewert R; Lange TJ; Klose H; Dumitrescu D; Halank M; Held M; Gall H; Pittrow D; Hoeper MM; Frankenstein L
    Clin Res Cardiol; 2018 Jun; 107(6):460-470. PubMed ID: 29368137
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry.
    Hoeper MM; Pausch C; Grünig E; Staehler G; Huscher D; Pittrow D; Olsson KM; Vizza CD; Gall H; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Rosenkranz S; Park DH; Ewert R; Kaemmerer H; Lange TJ; Kabitz HJ; Skowasch D; Skride A; Claussen M; Behr J; Milger K; Halank M; Wilkens H; Seyfarth HJ; Held M; Dumitrescu D; Tsangaris I; Vonk-Noordegraaf A; Ulrich S; Klose H
    Eur Respir J; 2022 Jun; 59(6):. PubMed ID: 34675047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis in Hispanic patient population with pulmonary arterial hypertension: An application of common risk stratification models.
    Fadah K; Cruz Rodriguez JB; Alkhateeb H; Mukherjee D; Garcia H; Schuller D; Mohammad KO; Sahay S; Nickel NP
    Pulm Circ; 2023 Apr; 13(2):e12209. PubMed ID: 37020706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model.
    Hoeper MM; Kramer T; Pan Z; Eichstaedt CA; Spiesshoefer J; Benjamin N; Olsson KM; Meyer K; Vizza CD; Vonk-Noordegraaf A; Distler O; Opitz C; Gibbs JSR; Delcroix M; Ghofrani HA; Huscher D; Pittrow D; Rosenkranz S; Grünig E
    Eur Respir J; 2017 Aug; 50(2):. PubMed ID: 28775047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk assessment in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
    Humbert M; Farber HW; Ghofrani HA; Benza RL; Busse D; Meier C; Hoeper MM
    Eur Respir J; 2019 Jun; 53(6):. PubMed ID: 30923187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simplified risk stratification for pulmonary arterial hypertension associated with connective tissue disease.
    Li X; Sun X; Huang Y; Wang Y; Yang X; Wang J; Zhang N; Gu L; Zhang M; Wang Q
    Clin Rheumatol; 2019 Dec; 38(12):3619-3626. PubMed ID: 31385084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.